{"url_path":"/sec/sprb/8-k/2026-05-13/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1683553/0001193125-26-220648-index.html","accession_number":"0001193125-26-220648","cik":"0001683553","ticker":"SPRB","issuer_name":"SPRUCE BIOSCIENCES, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1683553/0001193125-26-220648-index.html","primary_entity_key":"0001683553","primary_entity_name":"SPRUCE BIOSCIENCES, INC."},"word_count":82,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits.\n\nExhibit\n\nNumber\n\nExhibit Description\n\n99.1\n\n[Press Release of Spruce Biosciences, Inc., dated May 13, 2026](sprb-ex99_1.htm).\n\n104\n\nCover Page Interactive Data File (formatted as inline XBRL).\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\nSpruce Biosciences, Inc.\n\nDate: May 13, 2026\n\nBy:\n\n /s/ Samir Gharib\n\nSamir Gharib\n\nPresident and Chief Financial Officer"}